Literature DB >> 29892083

Plasticity in binding confers selectivity in ligand-induced protein degradation.

Radosław P Nowak1,2, Stephen L DeAngelo1, Dennis Buckley3,4, Zhixiang He1,2, Katherine A Donovan1,2, Jian An1,2, Nozhat Safaee1,2, Mark P Jedrychowski5,6, Charles M Ponthier1, Mette Ishoey3, Tinghu Zhang1,2, Joseph D Mancias5, Nathanael S Gray1,2, James E Bradner3,4, Eric S Fischer7,8.   

Abstract

Heterobifunctional small-molecule degraders that induce protein degradation through ligase-mediated ubiquitination have shown considerable promise as a new pharmacological modality. However, we currently lack a detailed understanding of the molecular basis for target recruitment and selectivity, which is critically required to enable rational design of degraders. Here we utilize a comprehensive characterization of the ligand-dependent CRBN-BRD4 interaction to demonstrate that binding between proteins that have not evolved to interact is plastic. Multiple X-ray crystal structures show that plasticity results in several distinct low-energy binding conformations that are selectively bound by ligands. We demonstrate that computational protein-protein docking can reveal the underlying interprotein contacts and inform the design of a BRD4 selective degrader that can discriminate between highly homologous BET bromodomains. Our findings that plastic interprotein contacts confer selectivity for ligand-induced protein dimerization provide a conceptual framework for the development of heterobifunctional ligands.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29892083      PMCID: PMC6202246          DOI: 10.1038/s41589-018-0055-y

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  51 in total

1.  A set of baculovirus transfer vectors for screening of affinity tags and parallel expression strategies.

Authors:  Wassim Abdulrahman; Muriel Uhring; Isabelle Kolb-Cheynel; Jean-Marie Garnier; Dino Moras; Natacha Rochel; Didier Busso; Arnaud Poterszman
Journal:  Anal Biochem       Date:  2008-11-07       Impact factor: 3.365

2.  Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.

Authors:  Georg Petzold; Eric S Fischer; Nicolas H Thomä
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

3.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

4.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

Authors:  Jing Lu; Yimin Qian; Martha Altieri; Hanqing Dong; Jing Wang; Kanak Raina; John Hines; James D Winkler; Andrew P Crew; Kevin Coleman; Craig M Crews
Journal:  Chem Biol       Date:  2015-06-04

5.  Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.

Authors:  Jeffrey L Gustafson; Taavi K Neklesa; Carly S Cox; Anke G Roth; Dennis L Buckley; Hyun Seop Tae; Thomas B Sundberg; D Blake Stagg; John Hines; Donald P McDonnell; John D Norris; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-17       Impact factor: 15.336

6.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α.

Authors:  Dennis L Buckley; Jeffrey L Gustafson; Inge Van Molle; Anke G Roth; Hyun Seop Tae; Peter C Gareiss; William L Jorgensen; Alessio Ciulli; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-12       Impact factor: 15.336

7.  BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.

Authors:  Georg E Winter; Andreas Mayer; Dennis L Buckley; Michael A Erb; Justine E Roderick; Sarah Vittori; Jaime M Reyes; Julia di Iulio; Amanda Souza; Christopher J Ott; Justin M Roberts; Rhamy Zeid; Thomas G Scott; Joshiawa Paulk; Kate Lachance; Calla M Olson; Shiva Dastjerdi; Sophie Bauer; Charles Y Lin; Nathanael S Gray; Michelle A Kelliher; L Stirling Churchman; James E Bradner
Journal:  Mol Cell       Date:  2017-06-29       Impact factor: 17.970

Review 8.  SPLINTS: small-molecule protein ligand interface stabilizers.

Authors:  Eric S Fischer; Eunyoung Park; Michael J Eck; Nicolas H Thomä
Journal:  Curr Opin Struct Biol       Date:  2016-01-30       Impact factor: 6.809

9.  Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.

Authors:  Jan Krönke; Emma C Fink; Paul W Hollenbach; Kyle J MacBeth; Slater N Hurst; Namrata D Udeshi; Philip P Chamberlain; D R Mani; Hon Wah Man; Anita K Gandhi; Tanya Svinkina; Rebekka K Schneider; Marie McConkey; Marcus Järås; Elizabeth Griffiths; Meir Wetzler; Lars Bullinger; Brian E Cathers; Steven A Carr; Rajesh Chopra; Benjamin L Ebert
Journal:  Nature       Date:  2015-07-01       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  101 in total

Review 1.  Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Authors:  Xinrui Yang; He Yin; Richard D Kim; Jason B Fleming; Hao Xie
Journal:  Target Oncol       Date:  2020-12-28       Impact factor: 4.493

Review 2.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

3.  Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling.

Authors:  Inchul You; Emily C Erickson; Katherine A Donovan; Nicholas A Eleuteri; Eric S Fischer; Nathanael S Gray; Alex Toker
Journal:  Cell Chem Biol       Date:  2019-12-16       Impact factor: 8.116

4.  Crystal structure of XCC3289 from Xanthomonas campestris: homology with the N-terminal substrate-binding domain of Lon peptidase.

Authors:  Rahul Singh; Sonali Deshmukh; Ashwani Kumar; Venuka Durani Goyal; Ravindra D Makde
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-09-16       Impact factor: 1.056

5.  Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay.

Authors:  Caroline A Foley; Frances Potjewyd; Kelsey N Lamb; Lindsey I James; Stephen V Frye
Journal:  ACS Chem Biol       Date:  2019-12-27       Impact factor: 5.100

Review 6.  PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future.

Authors:  Mariell Pettersson; Craig M Crews
Journal:  Drug Discov Today Technol       Date:  2019-02-13

7.  Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties.

Authors:  Saul Jaime-Figueroa; Alexandru D Buhimschi; Momar Toure; John Hines; Craig M Crews
Journal:  Bioorg Med Chem Lett       Date:  2019-12-13       Impact factor: 2.823

Review 8.  Emerging modes-of-action in drug discovery.

Authors:  Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T Plowright
Journal:  Medchemcomm       Date:  2019-06-25       Impact factor: 3.597

9.  Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Authors:  Carl C Ward; Jordan I Kleinman; Scott M Brittain; Patrick S Lee; Clive Yik Sham Chung; Kenneth Kim; Yana Petri; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

10.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.